States' choices set up national health experiment


WASHINGTON (AP) — President Barack Obama's health care overhaul is unfolding as a national experiment with American consumers as the guinea pigs: Who will do a better job getting uninsured people covered, the states or the feds?


The nation is about evenly split between states that decided by Friday's deadline they want a say in running new insurance markets and states that are defaulting to federal control because they don't want to participate in "Obamacare." That choice was left to state governments under the law: Establish the market or Washington will.


With some exceptions, states led by Democrats opted to set up their own markets, called exchanges, and Republican-led states declined.


Only months from the official launch, exchanges are supposed to make the mind-boggling task of buying health insurance more like shopping on Amazon.com or Travelocity. Millions of people who don't have employer coverage will flock to the new markets. Middle-class consumers will be able to buy private insurance, with government help to pay the premiums in most cases. Low-income people will be steered to safety net programs like Medicaid.


"It's an experiment between the feds and the states, and among the states themselves," said Robert Krughoff, president of Consumers' Checkbook, a nonprofit ratings group that has devised an online tool used by many federal workers to pick their health plans. Krughoff is skeptical that either the feds or the states have solved the technological challenge of making the purchase of health insurance as easy as selecting a travel-and-hotel package.


Whether or not the bugs get worked out, consumers will be able to start signing up Oct. 1 for coverage that takes effect Jan. 1. That's also when two other major provisions of the law kick in: the mandate that almost all Americans carry health insurance, and the rule that says insurers can no longer turn away people in poor health.


Barring last-minute switches that may not be revealed until next week, 23 states plus Washington, D.C., have opted to run their own markets or partner with the Obama administration to do so.


Twenty-six states are defaulting to the feds. But in several of those, Republican governors are trying to carve out some kind of role by negotiating with federal Health and Human Services Secretary Kathleen Sebelius. Utah's status is unclear. It received initial federal approval to run its own market, but appears to be reconsidering.


"It's healthy for the states to have various choices," said Ben Nelson, CEO of the National Association of Insurance Commissioners. "And there's no barrier to taking somebody else's ideas and making them work in your situation." A former U.S. senator from Nebraska, Nelson was one of several conservative Democrats who provided crucial votes to pass the overhaul.


States setting up their own exchanges are already taking different paths. Some will operate their markets much like major employers run their health plans, as "active purchasers" offering a limited choice of insurance carriers to drive better bargains. Others will open their markets to all insurers that meet basic standards, and let consumers decide.


Obama's Affordable Care Act remains politically divisive, but state insurance exchanges enjoy broad public support. Setting up a new market was central to former Republican presidential candidate Mitt Romney's health care overhaul as governor of Massachusetts. There, it's known as the Health Connector.


A recent AP poll found that Americans prefer to have states run the new markets by 63 percent to 32 percent. Among conservatives the margin was nearly 4-1 in favor of state control. But with some exceptions, including Idaho, Nevada and New Mexico, Republican-led states are maintaining a hands-off posture, meaning the federal government will step in.


"There is a sense of irony that it's the more conservative states" yielding to federal control, said Sandy Praeger, the Republican insurance commissioner in Kansas, a state declining to run its own exchange. First, she said, the law's opponents "put their money on the Supreme Court, then on the election. Now that it's a reality, we may see some movement."


They're not budging in Austin. "Texas is not interested in being a subcontractor to Obamacare," said Lucy Nashed, spokeswoman for Gov. Rick Perry, who remains opposed to mandates in the law.


In Kansas, Praeger supported a state-run exchange, but lost the political struggle to Gov. Sam Brownback. She says Kansans will be closely watching what happens in neighboring Colorado, where the state will run the market. She doubts that consumers in her state would relish dealing with a call center on the other side of the country. The federal exchange may have some local window-dressing but it's expected to function as a national program.


Christine Ferguson, director of the Rhode Island Health Benefits Exchange, says she expects to see a big shift to state control in the next few years. "Many of the states have just run out of time for a variety of reasons," said Ferguson. "I'd be surprised if in the longer run every state didn't want to have its own approach."


In some ways, the federal government has a head start on the states. It already operates the Medicare Plan Finder for health insurance and prescription plans that serve seniors, and the Federal Employees Health Benefits Program. Both have many of the features of the new insurance markets.


Administration officials are keeping mum about what the new federal exchange will look like, except that it will open on time and people in all 50 states will have the coverage they're entitled to by law.


Joel Ario, who oversaw planning for the health exchanges in the Obama administration, says "there's a rich dialogue going on" as to what the online shopping experience should look like. "To create a website like Amazon is a very complicated exercise," said Ario, now a consultant with Manatt Health Solutions.


He thinks consumers should be able to get one dollar figure for each plan that totals up all their expected costs for the year, including premiums, deductibles and copayments. Otherwise, scrolling through pages of insurance jargon online will be a sure turn-off.


Read More..

After decent rally, perhaps time for a pause

NEW YORK (Reuters) - Stocks could struggle to extend their seven-week winning streak as the quarterly earnings period draws to a close and the market bumps into strong technical resistance.


Many analysts say the market could spend the next few weeks consolidating gains that have lifted the benchmark Standard & Poor's 500 <.spx> by 6.6 percent since the start of the year.


The S&P 500 ended up 0.1 percent for the week, recovering from a late sell-off on Friday after a Bloomberg report about slow February sales at Wal-Mart triggered a slide in the retailer's shares. It was the index's seventh week of gains.


Odds of a pullback are increasing, with the market in slightly overbought territory, said Bruce Zaro, chief technical strategist at Delta Global Asset Management in Boston.


"I do suspect the closing of the earnings season will lead to at least a pause and possibly a pullback," Zaro said. The S&P 500 could shave 3 to 5 percent between now and early April, he said.


Fourth-quarter earnings have mostly beaten expectations. Year-over-year profit growth for S&P 500 companies is now estimated at 5.6 percent, up from a January 1 forecast for 2.9 percent growth, and 70 percent of companies are exceeding analyst profit expectations, above the 62 percent long-term average, according to Thomson Reuters data.


On Thursday, Wal-Mart, the world's largest retailer, is due to report results, unofficially closing out the earnings period. Investors will be keen to see its quarterly numbers, especially after the Friday's news report that rattled investors.


The S&P 500 has gained 4.3 percent since Alcoa kicked off the earnings season on January 8.


The approaching March 1 deadline for across-the-board federal budget cuts unless Congress reaches a compromise adds another reason for caution, especially with recent economic data indicating the recovery remains bumpy.


Manufacturing output fell 0.4 percent last month, the Federal Reserve said on Friday, but production in November and December was much stronger than previously thought.


TESTING RESISTANCE


The S&P 500 has been trading near five-year highs, and it notched its highest level since November 2007 this week. But the gains have pushed the benchmark index almost as far as it is likely to go in the near term, with strong resistance hovering around 1,525 and 1,540, one analyst said.


As a result, the index is set to move sideways, said Dave Chojnacki, market technician at Street One Financial in Huntington Valley, Pennsylvania. "We just don't have the volume or the catalyst right now" to go above those levels, he said.


At the same time, other analysts say, the market has not shown significant signs of slowing, including a break below 15- and 30-day moving averages.


Such moves would be needed to show that momentum is slowing or that the market is at risk of a correction, said Todd Salamone, director of research for Schaeffer's Investment Research in Cincinnati, Ohio. The S&P 500's 14-day moving average is at 1,511 while the 30-day is at 1,494. The index closed Friday at 1,519.


Recent M&A activity, including news this week of a merger between American Airlines and US Airways Group , helped provide some strength for the market this week and optimism that more deals may be on the way.


In the coming days, the market will focus on minutes from the latest Federal Reserve meeting, due to be released on Wednesday, which could provide support if they suggest the Fed will remain on its current course of aggressive monetary easing.


The Fed minutes released in January spooked markets a bit when they revealed that some Fed officials thought it would be appropriate to consider ending asset purchases later in 2013. U.S. Treasury yields rose on that news, though market worries about a near-term end to quantitative easing have since faded.


Among other companies expected to report earnings next week are Nordstrom , Hewlett-Packard and Marriott International


(Reporting By Caroline Valetkevitch; Editing by Leslie Adler)



Read More..

Loi Journal: In Vietnam, Some Chose to Be Single Mothers


Justin Mott for the International Herald Tribune


Nguyen Thi Nhan at home with her grandson, Thao, 2. Abandoned by her husband after the war, she asked another man to impregnate her. More Photos »







LOI, Vietnam — They had no plan to break barriers or cause trouble. But 30 years ago in this bucolic village in northern Vietnam, the fierce determination of one group of women to become mothers upended centuries-old gender rules and may have helped open the door for a nation to redefine parenthood.




One recent morning in Loi, as farmers in conical straw hats waded quietly through rice paddies, a small group of women played with their grandchildren near a stream. Their husbands were nowhere to be found, not because they perished in the war, but because the women decided to have children without husbands.


The women’s story began during the American War, as it is called here, when many put the revolution before their families. As peace settled more than a decade later, it became clear that they — like so many of their generation — had sacrificed their marriageable years to the war.


At that time Vietnamese women traditionally married around 16, and those still single at 20 would often be considered “qua lua,” or “past the marriageable age.” When single men who survived the war returned home, they often preferred younger brides, exacerbating the effects of a sex ratio already skewed by male mortality in the war. According to the Vietnam Population and Housing Census of 2009, after reunification in 1979 there were on average only about 88 men for every 100 women between 20 and 44.


Unlike previous generations of unwanted Vietnamese women who dutifully accepted the “so,” or “destiny,” of living a solitary life, a group of women in Loi decided to take motherhood into their own hands. They had endured the war, developed a new strength and were determined not to die alone.


One by one they asked men — whom they would never interact with afterward — to help them conceive a child. The practice became known as “xin con,” or “asking for a child,” and it meant breaking with tradition, facing discrimination and enduring the hardships of raising a child alone.


“It was unusual, and quite remarkable,” said Harriet Phinney, an assistant professor of anthropology at Seattle University who is writing a book on the practice of xin con in Vietnam. Purposely conceiving a child out of wedlock, she said, “was unheard-of” before the revolutionary era.


It was a product of the mothers’ bravery, said Ms. Phinney, but also of a postwar society that acknowledged the unique situation of women across Vietnam, including thousands of widows, who were raising children alone.


Some of the women in Loi were willing to share their stories, though they always kept the names of the fathers a tightly held secret. One of the first women in Loi to ask for a child was Nguyen Thi Nhan, now 58.


Ms. Nhan had led a platoon of women during the war, and though she never saw battle, was awarded a medal for her exemplary leadership. Her husband, with whom she had a daughter, abandoned her after the war. Ms. Nhan moved to the cheapest land she could find, a field near the stream on the outskirts of Loi, where a few refugees from bombing nearby still lived. She then asked for a second child, ending up with the son she wished for.


Her first several years were hard. Despite her best efforts, food and money were scarce. The villagers eventually set aside prejudices and accepted her choice, offering to share the little food they could spare. Eventually, Ms. Nhan was joined by more than a dozen other women. Among them was Nguyen Thi Luu, 63. She had fallen in love with a soldier who was killed in battle in 1972.


“I was 26 when the war ended,” Ms. Luu said. “That was considered too old for marriage, in those times. I did not want to marry a bad, older man, and no single men came to me.”


But Ms. Luu wanted to become a mother, not least so she would have support in her old age. In Vietnam, nursing homes are scarce, and care for the elderly is considered a filial duty.


“I was afraid to die alone,” Ms. Luu said. “I wanted someone to lean on in my old age. I wanted a child of my own.”


Read More..

American Idol's Top 40 Revealed






American Idol










02/14/2013 at 10:00 PM EST







From left: Randy Jackson, Mariah Carey, Ryan Seacrest, Nicki Minaj and Keith Urban


Michael Becker/FOX.


American Idol really, really wants a woman to win this season. At the beginning of Thursday's episode, they reminded us that a female singer hasn't won the show since 2007, when Jordin Sparks bested Blake Lewis for the top prize. Let's put this into perspective: The last time a woman won, George W. Bush was still president, J.K. Rowling was still writing the Harry Potter series, and no one had any idea who Snooki was. Well, maybe a few people knew her.

After Ryan Seacrest all but begged us to vote for a female, we finally got to see the level of the women's talent. Angela Miller sat at the piano and sang her own song, "You Set Me Free." It was a show-stopping performance, prompting judge Keith Urban to rave.

"If that was recorded right there, I would play it in my car," he said. "That was just a beautiful song."

Miller was followed by Candice Glover, who gave an strong version of Alicia Keys's "Girl on Fire." Janelle Arthur also impressed with a pleasant version of Carrie Underwood's "I told You So."

Shubha Vedula had the nerve to sing a Mariah Carey song in front of Mariah Carey and did a great job.

And then there was Zoanette Johnson. (At some point, she needs to drop her last name and just be known as Zoanette.) She played the drums as she sang a song she had improvised onstage the previous night. It was a rambling tune about her Idol experience. It was manic and baffling. And then she came to an abrupt stop and yelled at the background singers.

"Slow it down! C'mon guys," she pleaded. "I need this to be right." At some point, she lost a drumstick.

It's fun to imagine what Simon Cowell's reaction would be to her performances.

Kez Ban, the season's other memorable contestant, was quickly cut from the competition after singing her original song. There is clearly only room for one unpredictable contestant this season – and her name is Zoanette.

As the show wound down, the judges cut the field down to 20 women, and then brought in the remaining 28 male singers to cut them down to 20. That's when the judges had Josh Holiday sing "Georgia on My Mind." He split his pants from crotch to knee.

But Holiday and 39 others are season 12's top 40. One of them will be the next American Idol. Will it be a girl?

Top 20 Women

Adriana Latonio
Amber Holcomb
Angela Miller
Aubrey Cleland
Brandy Hotard
Breanna Steer
Candice Glover
Cristabel Clack
Isabelle Pasqualone
Janelle Arthur
Jenny Beth Willis
Jett Hermano
Juliana Chahayed
Kamaria Ousley
Kree Harrison
Melinlda Ademi
Rachel Hale
Shubha Vedula
Tenna Torres
Zoanette Johnson

Top 20 Men

Bryant Tadeo
Burnell Taylor
Charlie Askew
Chris Watson
Cortez Shaw
Curtis Finch, Jr.
David Willis
Devin Velez
Elijah Liu
Gurpreet Singh Sarin
Jimmy Smith
Johnny Keyser
Josh Holiday
Kevin Harris
Lazaro Arbos
Mathenee Treco
Nick Boddington
Paul Jolley
Vincent Powell
Read More..

Study: Fish in drug-tainted water suffer reaction


BOSTON (AP) — What happens to fish that swim in waters tainted by traces of drugs that people take? When it's an anti-anxiety drug, they become hyper, anti-social and aggressive, a study found. They even get the munchies.


It may sound funny, but it could threaten the fish population and upset the delicate dynamics of the marine environment, scientists say.


The findings, published online Thursday in the journal Science, add to the mounting evidence that minuscule amounts of medicines in rivers and streams can alter the biology and behavior of fish and other marine animals.


"I think people are starting to understand that pharmaceuticals are environmental contaminants," said Dana Kolpin, a researcher for the U.S. Geological Survey who is familiar with the study.


Calling their results alarming, the Swedish researchers who did the study suspect the little drugged fish could become easier targets for bigger fish because they are more likely to venture alone into unfamiliar places.


"We know that in a predator-prey relation, increased boldness and activity combined with decreased sociality ... means you're going to be somebody's lunch quite soon," said Gregory Moller, a toxicologist at the University of Idaho and Washington State University. "It removes the natural balance."


Researchers around the world have been taking a close look at the effects of pharmaceuticals in extremely low concentrations, measured in parts per billion. Such drugs have turned up in waterways in Europe, the U.S. and elsewhere over the past decade.


They come mostly from humans and farm animals; the drugs pass through their bodies in unmetabolized form. These drug traces are then piped to water treatment plants, which are not designed to remove them from the cleaned water that flows back into streams and rivers.


The Associated Press first reported in 2008 that the drinking water of at least 51 million Americans carries low concentrations of many common drugs. The findings were based on questionnaires sent to water utilities, which reported the presence of antibiotics, sedatives, sex hormones and other drugs.


The news reports led to congressional hearings and legislation, more water testing and more public disclosure. To this day, though, there are no mandatory U.S. limits on pharmaceuticals in waterways.


The research team at Sweden's Umea University used minute concentrations of 2 parts per billion of the anti-anxiety drug oxazepam, similar to concentrations found in real waters. The drug belongs to a widely used class of medicines known as benzodiazepines that includes Valium and Librium.


The team put young wild European perch into an aquarium, exposed them to these highly diluted drugs and then carefully measured feeding, schooling, movement and hiding behavior. They found that drug-exposed fish moved more, fed more aggressively, hid less and tended to school less than unexposed fish. On average, the drugged fish were more than twice as active as the others, researcher Micael Jonsson said. The effects were more pronounced at higher drug concentrations.


"Our first thought is, this is like a person diagnosed with ADHD," said Jonsson, referring to attention deficit-hyperactivity disorder. "They become asocial and more active than they should be."


Tomas Brodin, another member of the research team, called the drug's environmental impact a global problem. "We find these concentrations or close to them all over the world, and it's quite possible or even probable that these behavioral effects are taking place as we speak," he said Thursday in Boston at the annual meeting of the American Association for the Advancement of Science.


Most previous research on trace drugs and marine life has focused on biological changes, such as male fish that take on female characteristics. However, a 2009 study found that tiny concentrations of antidepressants made fathead minnows more vulnerable to predators.


It is not clear exactly how long-term drug exposure, beyond the seven days in this study, would affect real fish in real rivers and streams. The Swedish researchers argue that the drug-induced changes could jeopardize populations of this sport and commercial fish, which lives in both fresh and brackish water.


Water toxins specialist Anne McElroy of Stony Brook University in New York agreed: "These lower chronic exposures that may alter things like animals' mating behavior or its ability to catch food or its ability to avoid being eaten — over time, that could really affect a population."


Another possibility, the researchers said, is that more aggressive feeding by the perch on zooplankton could reduce the numbers of these tiny creatures. Since zooplankton feed on algae, a drop in their numbers could allow algae to grow unchecked. That, in turn, could choke other marine life.


The Swedish team said it is highly unlikely people would be harmed by eating such drug-exposed fish. Jonsson said a person would have to eat 4 tons of perch to consume the equivalent of a single pill.


Researchers said more work is needed to develop better ways of removing drugs from water at treatment plants. They also said unused drugs should be brought to take-back programs where they exist, instead of being flushed down the toilet. And they called on pharmaceutical companies to work on "greener" drugs that degrade more easily.


Sandoz, one of three companies approved to sell oxazepam in the U.S., "shares society's desire to protect the environment and takes steps to minimize the environmental impact of its products over their life cycle," spokeswoman Julie Masow said in an emailed statement. She provided no details.


___


Online:


Overview of the drug: http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682050.html


Read More..

ARCHOS debuts three quad-core iPad clones with HD displays and affordable price tags






ARCHOS (JXR) on Thursday announced a new line of “Platinum” tablets that feature high-end specs and a low price tag. The company debuted three different sized tablets — 8-inch, 9.7-inch and 11.6-inch — that are equipped with high-definition IPS displays, 1.2GHz quad-core processors, microSD ports, 2GB of RAM and Android 4.1. The 8-inch Platinum slate features a 1024 × 768 resolution screen and will be priced at $ 199, while the 9.7-inch Platinum HD tablet, which looks strikingly similar to Apple’s (AAPL) iPad, will be equipped with a 2048 × 1536 resolution display and will sell for $ 299. Both tablets will be released this month, while the largest Platinum slate will be available in April and offer a 1920 × 1080 resolution screen for $ 349. ARCHOS’ press release follows below.


[More from BGR: After using Microsoft’s Surface Pro, going back to the first Surface is agonizing]







ARCHOS Introduces the New Platinum Range
The Platinum tablets are amongst the first Android tablets to offer a super high resolution IPS screen combined with the performance of a Quad-Core CPU

Denver, CO – February 14, 2013 – ARCHOS, an award-winning innovator in consumer electronics, introduces the Platinum range, a new line of tablets that feature a sleek aluminum design combined with the best high definition IPS displays, quad-core processors and Android 4.1 Jelly Bean. There will be three tablets in the range including an 8-inch, 9.7-inch and 11.6-inch all of which deliver true vivid colors, sharper text and amazingly fast performance.


[More from BGR: Every 10 years, a cataclysm kills off most phone brands – the next one is almost here]


The entire Platinum range will all share the following features:
• High-Definition IPS display with capacitive multi-touch screen
• QUAD core CPU at 1.2 GHz with 8-core GPU, with 1080p video decoding
• 2 GB RAM
• Android 4.1 Jelly Bean
• Full access to the 700,000 applications
• Archos Media Center applications
• Front and Back Cameras
• Mini-HDMI and Micro SD ports


The ARCHOS 80 Platinum, an 8” tablet, features a 1024×768 resolution IPS screen and when compared to the Kindle Fire HD 8.9 it is almost twice as fast, has double the RAM and has a back camera for a fraction of the cost. The 80 Platinum will be available in February for $ 199.


The ARCHOS 97 Platinum HD, a 9.7” tablet, features a stunning 2048×1536 resolution IPS screen, which is comparable to the Retina display found in the iPad, but is 40% less expensive.
The 97 Platinum HD will be available in February for $ 299.


The ARCHOS 116 Platinum, an 11.6” tablet, features a 1920×1080 resolution IPS screen, unlike anything currently on the market. The 116 Platinum will be available in April for $ 349.



This article was originally published on BGR.com


Wireless News Headlines – Yahoo! News




Read More..

Lady Gaga Cancels Born This Way Ball Tour Due to Severe Injury















02/13/2013 at 08:50 PM EST



It's a somber week for Lady Gaga – and her Little Monsters.

Following Tuesday's Facebook announcement that she was "devastated and sad" because she couldn't walk and had to postpone several Born This Way Ball concerts, the pop star, 26, has officially canceled the remaining dates of her world tour.

"After additional tests this morning to review the severity of the issue, it has been determined that Lady Gaga has a labral tear of the right hip," the singer's rep told PEOPLE Wednesday in a statement. "She will need surgery to repair the problem, followed by strict down time to recover. This unfortunately, will force her to cancel the tour, so she can heal."

Refunds for the cancelled performances will be available at point of purchase starting on Thursday.

"I hope you can forgive me, as it is nearly impossible for me to forgive myself," she wrote the previous day of postponing the dates. "I hate this. I hate this so much. I love you and I'm sorry."

Get well, Gaga!

Reporting by CHUCK ARNOLD

Read More..

Clues to why most survived China melamine scandal


WASHINGTON (AP) — Scientists wondering why some children and not others survived one of China's worst food safety scandals have uncovered a suspect: germs that live in the gut.


In 2008, at least six babies died and 300,000 became sick after being fed infant formula that had been deliberately and illegally tainted with the industrial chemical melamine. There were some lingering puzzles: How did it cause kidney failure, and why wasn't everyone equally at risk?


A team of researchers from the U.S. and China re-examined those questions in a series of studies in rats. In findings released Wednesday, they reported that certain intestinal bacteria play a crucial role in how the body handles melamine.


The intestines of all mammals teem with different species of bacteria that perform different jobs. To see if one of those activities involves processing melamine, researchers from the University of North Carolina at Greensboro and Shanghai Jiao Tong University gave lab rats antibiotics to kill off some of the germs — and then fed them melamine.


The antibiotic-treated rats excreted twice as much of the melamine as rats that didn't get antibiotics, and they experienced fewer kidney stones and other damage.


A closer look identified why: A particular intestinal germ — named Klebsiella terrigena — was metabolizing melamine to create a more toxic byproduct, the team reported in the journal Science Translational Medicine.


Previous studies have estimated that fewer than 1 percent of healthy people harbor that bacteria species. A similar fraction of melamine-exposed children in China got sick, the researchers wrote. But proving that link would require studying stool samples preserved from affected children, they cautioned.


Still, the research is pretty strong, said microbiologist Jack Gilbert of the University of Chicago and Argonne National Laboratory, who wasn't involved in the new study.


More importantly, "this paper adds to a growing body of evidence which suggests that microbes in the body play a significant role in our response to toxicity and in our health in general," Gilbert said.


Read More..

Microsoft now sees the Xbox as an ‘entertainment’ console that’s not limited to gaming








Read More..

Wall Street pauses after rally to five-year high

NEW YORK (Reuters) - Stocks drifted in light volume on Wednesday, ending little changed, as investors remained cautious after the S&P 500 index briefly hit its highest intraday level since November 2007.


The S&P 500 was buoyed by General Electric after cable company Comcast Corp said it will buy from GE the the part of NBCUniversal it didn't already own for $16.7 billion.


Comcast's stock hit the highest since 1999 before closing up 3 percent at $40.13 and GE gained 3.6 percent to $23.39.


The S&P 500 is up 6.6 percent so far this year, partly due to stronger-than-expected corporate earnings and a better economic outlook. The Dow industrials is about 1 percent away from an all-time intraday high, reached in October 2007.


Volume has been weak in recent days with the S&P moving sideways around 1,520. The index is about 3 percent away from closing at a record high.


A scarcity of sellers after a consistent string of gains is a positive sign and shows the uptrend is intact, King Lip, chief investment officer at Baker Avenue Asset Management in San Francisco, said.


"Last year we had double-digit returns in the first quarter. It's fairly possible we can move higher from here," he said.


The Dow Jones industrial average <.dji> fell 35.79 points or 0.26 percent, to 13,982.91, the S&P 500 <.spx> gained 0.9 point or 0.06 percent, to 1,520.33 and the Nasdaq Composite <.ixic> added 10.38 points or 0.33 percent, to 3,196.88.


The S&P gained 12 percent in the first three months of 2012.


Deere & Co , the world's largest farm equipment maker, forecast a modest increase in sales this year despite the prospect of the biggest corn crop in U.S. history. The forecast fell short of analysts' expectations, sending shares of Deere down 3.5 percent to $90.68.


In extended trading, shares of technology bellwether Cisco Systems fell 2 percent after it posted results.


Dr Pepper Snapple fell 5.8 percent to $42.69 after it forecast profit for the current year below analysts' estimates.


Cliffs Natural Resources lost a fifth of its market value a day after the miner reported a quarterly loss and slashed its dividend by 76 percent. Its shares fell 20 percent to 429.29.


According to the latest Thomson Reuters data, of the 364 companies in the S&P 500 that have reported results, 70.3 percent have exceeded analysts' expectations, above a 62 percent average since 1994 and 65 percent over the past four quarters.


About 5.9 billion shares changed hands on the New York Stock Exchange, the Nasdaq and NYSE MKT, below the daily average in February last year of 6.94 billion.


On the NYSE, roughly seven issues rose for every five that fell and on Nasdaq more than six rose for every five decliners.


(Editing by Kenneth Barry and Bernadette Baum)



Read More..